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Open access under the ElvsevStudies have shown that Casearia sylvestris compounds protect DNA from damage both in vitro and
in vivo. Complementarily, the aim of the present study was to assess the chemopreventive effect of case-
arin B (CASB) against DNA damage using the Ames test, the comet assay and the DCFDA antioxidant
assay. The genotoxicity was assessed by the comet assay in HepG2 cells. CASB was genotoxic at concen-
trations higher than 0.30 lM when incubated with the FPG (formamidopyrimidine-DNA glycosylase)
enzyme. For the antigenotoxicity comet assay, CASB protected the DNA from damage caused by H2O2
in the HepG2 cell line in concentrations above 0.04 lM with post-treatment, and above 0.08 lM with
pre-treatment. CASB was not mutagenic (Ames test) in TA 98 and TA 102. In the antimutagenicity assays,
the compound was a strong inhibitor against aﬂatoxin B1 (AFB) in TA 98 (>88.8%), whereas it was mod-
erate (42.7–59.4%) inhibitor against mytomicin C (MMC) in TA 102. Additionally, in the antioxidant assay
using DCFDA, CASB reduced reactive oxygen species (ROS) generated by H2O2. In conclusion, CASB was
genotoxic to HepG2 cells at high concentrations; was protective of DNA at low concentrations, as shown
by the Ames test and comet assay; and was also antioxidant.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction Extracts and chemical components of C. sylvestris, particularlyCasearia sylvestris is a plant commonly known in Brazil as
‘‘guaçatonga,’’ and its leaves are widely used for their anti-inﬂam-
matory and anti-ulcerative activities (Basile et al., 1990; Borges
et al., 2000; Sertié et al., 2000). In addition, the bark of C. sylvestris
has been used to treat fever symptoms and for treatment of herpes
virus and diarrhea (Esteves et al., 2005). Phytochemical investiga-
tions revealed that the major compounds isolated from C. sylvestris
(clerodane diterpenes) exhibited anti-fungal activities (Oberlies
et al., 2002).thramine; AFB, aﬂatoxin B1;
diacetate; FPG, formamido-
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ier OA license. clerodane diterpenes, showed cytotoxic activity against tumor
cells. Speciﬁcally to the casearin B (CASB), there is only one pub-
lished study concerning its biological activity, which accessed the
cytotoxicity of the sample against human cell lines using MTT as-
say. The study presents the following CASB cytotoxicity results:
MOLT-4 (leukemia; IC50 = 0.22 lM), MDA-MB-435 (melanoma;
IC50 = 0.35 lM), HCT-8 (colon cancer; IC50 = 0.97 lM), and SF-295
(glioblastoma; IC50 = 0.43 lM), whereas CASB was less cytotoxic
to L-929 cells (normal ﬁbroblasts; IC50 = 1.52 lM) demonstrating
a more selective cytotoxic response to tumor cell lines (dos Santos
et al., 2010). However, there are no further mechanistic investiga-
tions concerning these results.
Regarding the effects of C. sylvestris compounds on DNA, studies
have reported the absence of genotoxic activity of an ethanolic
extract from the leaves of C. sylvestris in HTC (hepatoma) and
V79 cells (Chinese hamster lung cells) using comet assays (Maistro
et al., 2004). Additionally, the essential oil of the leaves was anti-
clastogenic when evaluated by observing chromosome aberrations
in HTC cells (Sousa et al., 2007). Recently, a study using mouse
blood cells showed that an ethanolic extract and caseargrewiin F
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toxic and mutagenic in high concentrations (de Oliveira et al.,
2009).
In fact, currently, there are a range of studies that investigate
compounds isolated from plants that protect DNA from damage,
elucidating the possible mechanisms by which these reductions
in DNA damage occur. To complement the previous studies per-
formed with C. sylvestris compounds, the aim of the present study
was to assess the chemopreventive effect of CASB using the comet
assay, the Ames test and an antioxidant assay.2. Materials and methods
2.1. Chemicals
Dulbecco’s Modiﬁed Eagle Medium (DMEM), antibiotic–antimycotic solution,
kanamycin sulfate, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) (CAS # 298-93-1), dimethylsulfoxide (DMSO) (CAS # 67-68-5), formaldehyde
(CAS # 50-00-0), mitomycin C (MMC) (CAS # 50-07-7), 2-aminoﬂuorene (2-AF)
(CAS # 153-78-6), 4-nitro-o-phenylenediamine (NPD) (CAS # 99-56-9), 2-anthra-
mine (2-AN) (CAS # 613-13-8) and aﬂatoxin B1 (AFB) were purchased from Sig-
ma–Aldrich (St. Louis, Missouri, USA). Fetal calf serum (FCS) was obtained from
Cultilab (Campinas, São Paulo, BRA). Sterile H2O2 (CAS # 7722-84-1), ethanol
(CAS # 64-17-5), silica (CAS # 7631-86-9), hexane (CAS # 110-82-7), ethyl acetate
(CAS # 141-78-6) and isopropanol (CAS # 67-63-0) were purchased from Merck
(Darmstadt, Hessen, DEU). Doxorubicin (Dox) (CAS # 23214-92-8) was purchased
from Eurofarma (São Paulo, BRA). FPG endonuclease was purchased from New
England Biolabs (Ipswich, MA, USA). S9 mixture was obtained from Moltox
(Boone, NC, USA). Activated charcoal was purchased from Synth (Diadema, São
Paulo, BRA).2.2. Preparation of extract, and puriﬁcation and structure determination of CASB
Dried and powdered leaves of C. sylvestris (20.5 kg) were extracted with ethanol
in a stainless steel extractor with solvent re-circulation for 24 h at 40 C. The crude
extract was concentrated under reduced pressure to yield 1540.0 g of dry residue. A
portion (473.6 g) of the residue was separated by SPE (solid-phase extraction) from
silica (60–200 lm)/activated charcoal (1:1, w/w) by elution with hexane/ ethyl ace-
tate (95:5, v/v), ethyl acetate, and methanol to afford three fractions (SPE1-SPE3).
SPE2 (16.0 g) was submitted to normal-phase LPCC (low-pressure column chroma-
tography) over silica (40–63 lm) eluted with a gradient of hexane/ethyl acetate/
isopropanol of increasing polarity (78:20.5:1.5 to 60:37.3:2.7, v/v): 45 fractions
were collected and monitored by TLC (thin layer chromatography), HPLC-UV
(High-performance liquid chromatography-ultraviolet), and 1H NMR (nuclear mag-
netic resonance). Fractions 15–19 were submitted to preparative reversed-phase
HPLC (C18 column; 250  50 mm; 12 lm) with methanol/ water mixture (67:33Fig. 1. Chemical structure of CASB.or 75:25, v/v) as the mobile phase to yield CASB (250.6 mg), Fig. 1. The compound
was identiﬁed by spectrometric analysis using NMR, MS (mass spectrometry), IR
(infrared) and UV, as described by dos Santos et al. (2010).
2.3. Cell culture
The HepG2 cell line was purchased from the Rio de Janeiro Cell Bank, Brazil. Be-
cause this cell line was obtained from a human hepatocellular carcinoma, there are
studies showing that it can express hepatic enzymes such as lipase, reductase and
catalase (Busch et al., 1990; Cuthbert et al., 1997), leading to a protective effect
against promutagens (Wilkening et al., 2003), making it a good model to test anti-
oxidant properties. Additionally, HepG2 cell line showed to be highly sensitive to-
ward several genotoxicants that give negative results in other in vitro assays such as
mycotoxins (Knasmüller et al., 2004a), becoming a very suitable tool for genotoxi-
city testing (Knasmüller et al., 2004b). Additionally, there are no studies concerning
if CASB is a phase I/II inductor, which makes HepG2 more suitable to test CASB since
there are studies that show that HepG2 cell line is sensitive to both phase I and II
inductors genotoxicants (Majer et al., 2004). The cells were grown in 75 cm3 ﬂasks
(Techno Plastic Products, Trasadingen, CHE) with loosened caps, containing DMEM
supplemented with 10% FCS (v/v), antibiotic–antimycotic Solution (1000 U of pen-
icillin, 100 lg/mL of streptomycin sulfate and 0.25 lg/mL amphotericin B), and
kanamycin sulfate (100 lg/mL) at 37 C in a CO2 incubator (Thermo Fisher Scientiﬁc
Inc., MA, USA) under a humidiﬁed atmosphere composed of 5% CO2 in 95% air.
2.4. Viability
As proposed by Tice et al. (2000), the comet assay must be performed in condi-
tions of low cytotoxicity; consequently the genotoxicity and antigenotoxicity of the
HepG2 cells were assessed under the IC20 obtained from the MTT assay. The anti-
mutagenicity was assessed under non-cytotoxic conditions using the Ames test,
as previously performed in Salmonella typhimurium strains.
2.4.1. MTT assay
For the MTT assay, 104 cells/well were seeded in a 96 well plate, then the cells
were exposed to at least ﬁve different concentrations of CASB compounds for a per-
iod of 24 h in triplicate, for three independent experiments. The treatments were:
(1) negative control (DMEM), (2) positive control (Dox at 15 lg/mL), (3) vehicle
control (DMEM plus DMSO 0.05% (v/v)), (4) ﬁve different concentrations of CASB
(0.65–10.00 lM). After the treatments, the MTT assay was performed as described
by Mosmann (1983). Finally, the viability was obtained using the following for-
mula: viability (%) = (treatments  100)/(negative control).
2.4.2. Viability in
S. typhimurium First, the culture medium, bacteria (TA98 or TA102), sterile
physiological solution and the compound to be tested were homogenized by vor-
texing. Subsequently, the mixture was added to tubes with 9 mL of sterile physio-
logical solution to obtain a dilution of 1:10, which was homogenized, and a ﬁnal
volume of 1 mL was transferred to another tube with the same amount of physio-
logical solution; this procedure was repeated to obtain a dilution of 105. From the
tube containing a dilution of 105, 0.1 mL was seeded on nutrient agar plates, then
incubated for 24 h at 37 C. After this period, the colonies were counted and the col-
ony-forming units/mL was calculated (CFU = colonies  dilution  10). The percent-
age of viability for each treatment was compared to the number of colonies from
the negative control. According to Vargas et al. (1993), cytotoxicity was considered
for samples with a percentage of viability below 60%.
2.5. Comet assay
2.5.1. Genotoxicity
HepG2 cells were seeded in 24-well plates (5  104 cells/well) and treated for
24 h with ﬁve concentrations of CASB using 1:2 dilution ratio. The treatments for
the comet assay were performed to allow the cells to complete at least one entire
cell cycle (24 h); in this way, it was possible to assess the damages that the cells
were not able to repair. The CASB concentrations tested were: 0.15, 0.30, 0.60,
1.20 and 2.30 lM. DMEM plus 0.05% DMSO and 0.5% Hank’s solution (v:v) was used
as vehicle control (VC); for the negative control (NC), the cells were treated only
with DMEM; and for the positive control, the cells were treated with 1 mM H2O2
for 10 min. The concentration of hydrogen peroxide was obtained by absorbance
as proposed by Brestel (1985). After the treatments, the cells were detached, re-sus-
pended and homogenized with low-melting-point agarose, spread on a microscope
slide pre-coated with normal-melting-point agarose and covered with a coverslip.
Then, the slides were incubated for 30 min with 90 lL of FPG enzyme (1:3000,
v:v) at 37 C, to speciﬁcally assess the oxidative damage in the DNA (Collins
et al., 2008). Additionally, an experiment without FPG incubation was also per-
formed. The alkaline version of the comet assay (single cell gel electrophoresis)
was performed as described by Singh et al. (1988). Duplicate slides were prepared
and stained with ethidium bromide, and 50 cells were screened per sample with a
ﬂuorescent microscope (ZEISS, Jena, Thuringia, DEU) equipped with an excitation
ﬁlter of 515–560 nm, a barrier ﬁlter of 590 nm and a 40 objective. The level of
Fig. 2. MTT viability assay of CASB in the HepG2 cell line treated with the
compound for 24 h. IC20 = 1.15 lM.
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2006, Sumerduck, VA, USA), and the DNA percent in the tail was obtained for each
treatment. The groups treated with the compounds were compared with the vehicle
control using the Kruskal–Wallis test and the associated Dunn post-test using the
OriginPro 8.0 software (OriginLab, Northampton, MA, USA).
2.5.2. Antigenotoxicity
HepG2 cells were pre-treated with CASB and were then exposed to 1 mM of
H2O2 for 10 min, or the cells were exposed to H2O2 1 mM for 10 min and post-trea-
ted with the CASB. Five concentrations were tested: 0.02, 0.04, 0.08, 0.15 and
0.30 lM. The positive control consisted of treating with H2O2 (1 mM) for 10 min,
and the cells were pre- or post-treated with DMEM, negative control (DMEM)
and vehicle control (cells pre- or post-treated with 0.05% DMSO plus Hank’s 0.5%
in DMEM plus H2O2 (1 mM)). Subsequently, the comet assay was performed as pre-
viously described for the genotoxicity assay, incubating the slides with FPG enzyme
(1:3000, v:v) because the mutagen used in this test was H2O2. Statistical analysis
was performed using the Kruskal–Wallis test and the associated Dunn post-test
to compare the treated groups with the vehicle control group using the OriginPro
8.0 software (OriginLab, Northampton, MA, USA). The damage inhibition percent
(I) was calculated as proposed by Hosseinimehr and Karami (2005): I = [(Positive
control)  (Test)]  100/(Positive control). Additionally, the percentage of inhibi-
tion was classiﬁed as strong (higher than 60%), moderate (60–41%), weak (40–
21%) and negligible (20–0%) (Calomme et al., 1996).
2.6. Ames test
2.6.1. Mutagenicity
Mutagenicity was evaluated by the Salmonella/microsome assay that is based
on the plate-incorporation method proposed by Maron and Ames (1983), using S.
typhimurium test strains TA98 and TA102, provided by Dr. B.N. Ames (Berkeley,
CA, USA), both with and without metabolization by the S9 mixture. The test strains
were obtained from frozen cultures and were grown overnight for 12–14 h at 37 C
in oxoid nutrient broth No. 2. The CASB was dissolved in DMSO and added to 2 mL
of top agar mixed with 100 lL of bacterial culture (1–2  108 cells/mL) and were
then added to a plate with minimal agar. Then, the plates were incubated at
37 C for 48 h and the number of His+ revertant colonies was manually counted.
Additionally, the inﬂuence of metabolic activation was assessed by adding 500 lL
of S9 mixture (S9 at a concentration of 0.04 mL/mL of mix). All experiments were
analyzed in triplicate. The standard mutagens used as positive controls in each
experiment were: TA 102 (S9) MMC (0.5 lg/plate), TA 102 (+S9) 2-AF (10 lg/
plate), TA 98 (S9) NPD (10 lg/plate), TA98 (+S9) 2-AN (1.25 lg/plate). DMSO
was used as the negative (vehicle) control (100 lL – maximum volume that was
used in the assay). We selected the concentrations based on the toxicity. In a pre-
liminary test, we considered toxicity to be when we observed either a reduction
in the number of his+ revertants, or an alteration in the auxotrophic background
(i.e., background lawn). In all subsequent assays, the upper limit of the dose range
tested was the highest nontoxic dose or the lowest toxic dose determined in this
assay. In the mutagenicity assay, we used the following concentrations: 0.03;
0.05; 0.10, 0.15 and 0.21 mg/plate. Statistical analysis was performed using the Sal-
anal software (Integrate Laboratory Service, NC, USA, 1992), adopting the Bernstein
et al. (1982) model. The mutagenic index (MI) was also calculated for each dose;
that is, the average number of revertants per plate divided by the average number
of revertants per plate in the negative (solvent) control. A sample was considered
positive when MIP 2 for at least one of the tested doses, and there was a reproduc-
ible dose–response curve (Varella et al., 2004).
2.6.2. Antimutagenicity
Before assessing the antimutagenicity, the cytotoxicity of the highest dose of
the compounds associated with the mutagen was tested. Based on the results of this
preliminary assay, the C. sylvestris components were tested in non-cytotoxic doses
for their antimutagenic properties. The procedures for the antimutagenicity assays
were similar to those described for the mutagenicity assays, except that in each
tube of top agar containing the bacterial strain and the CASB, the mutagenic agent
was also added. One of the mutagens tested was a direct-acting genotoxic com-
pound, MMC in TA 102 (4  107 mg/plate); while the other was the indirect-acting
promutagen AFB in TA 98 (5  107 mg/plate). In addition to AFB, the promutagen-
activating fraction S9 was added. This fraction was prepared and used following
Maron and Ames (1983). Toxicity to the various bacteria was also tested, and the
sample concentrations employed for the antimutagenic test were all found to be
non-toxic. The following CASB concentrations were used in the antimutagenicity
assay: 0.02; 0.03; 0.05; 0.10 mg/plate. The concentration of CASB that inhibits
50% of mutagenicity (MID50) was obtained using regression analysis (OriginPro
8.0 software – OriginLab, Northampton, MA, USA). The calculation of the
percentage of mutagenic inhibition (I) was carried out as described by Tachino
et al. (1994). We also classiﬁed the mutagenic inhibition as described in antigeno-
toxicity assay.
I¼ ½1ðrevertants per plate with inhibitor=revertants per plate without inhibitorÞ
1002.7. Antioxidant assay
The intracellular reactive oxygen species (ROS) were measured using 20 ,70-
dichlorodihydroﬂuorescein diacetate (DCFDA). Inside the cell, DCFDA (inactive
ROS) is converted to DCFH (active ROS) by an esterase. H2O2 and other ROS oxidize
intracellular DCFH (non-ﬂuorescent) to DCF (ﬂuorescent). HepG2 cells (104 cells/
well) were seeded in sterile black plates. Then, the cells were treated with CASB
in three concentrations: 0.04, 0.08 and 0.15 mM for 24 h with their respective con-
trols. The concentrations of this compound were chosen based on previously ob-
tained results of cytotoxicity and genotoxicity assays. Additionally, the following
controls were used for the experiment: (1) negative control (NC) cells (cells main-
tained in culture medium), (2) vehicle control (VC) (cells treated with 0.05% DMSO
plus Hank’s 0.5% in DMEM) and (3) quercetin (a natural antioxidant) control (Q)
(40 mM). After treatment, the wells were washed twice with Hank’s solution. Next,
100 lL of a solution of 5 mM DCFDA diluted in Hank’s was added and incubated for
30 min at 37 C while protected from light. Thereafter, 1 mM hydrogen peroxide
was added for 10 min, after which time the hydrogen peroxide was removed from
the plate by aspiration. The wells were washed twice with Hank’s, and 100 lL of
Hank’s solution was added to each well for reading with a ﬂuorimeter. Reading
was performed every minute for 30 min, at excitation: k = 485 nm, emission:
k = 528 nm. A curve of ﬂuorescence intensity versus time was plotted, and from this
curve, the total ﬂuorescence intensity for each treatment was estimated by obtain-
ing the integral of each curve (area under the curve) using the OriginPro 8.0 soft-
ware (OriginLab, Northampton, MA, USA). Three independent experiments were
performed in triplicate. Next, a one-way analysis of variance (ANOVA) was per-
formed with the Dunnett post-test to compare the total intensities obtained from
the treatments versus the vehicle control (VC) (Nakajima et al., 2009).3. Results
3.1. Viability and genotoxicity
Before the effect of the compounds on the DNA in the HepG2
cell line was assessed, the MTT assay was performed. The assays
were conducted under the IC20, 2.3 lM (Fig. 2). Complementarily,
the results, shown in Fig. 2, demonstrate that this compound was
genotoxic to HepG2 cells at concentrations above 0.30 lM when
incubated with FPG enzyme, whereas without the enzyme incuba-
tion, CASB begins to show genotoxicity at 1.15 lM (Fig. 3).
3.2. Antigenotoxicity
To assess antigenotoxicity, concentrations that slightly affected
the cell viability and that were not genotoxic were chosen. CASB
signiﬁcantly reduced the DNA damage caused by H2O2 in HepG2
cells in both pre- (0.08 and 0.15 lM) and post-treatments (0.04,
0.08 and 0.15 lM) (Fig. 4A). With regard to the percent inhibition
of DNA damage (Fig. 4B), the post-treatment was the most
Fig. 3. Genotoxicity in the HepG2 cell line exposed to CASB for 24 h assessed by the
comet assay, with and without incubation with FPG enzyme. NC = negative control
(cells in cell culture medium, DMEM); VC = vehicle control (cells treated with DMSO
0.05%, Hank’s 0, 5% in DMEM). Kruskal–Wallis with Dunn post-test VC versus
treatments: ⁄p < 0.05; ⁄⁄p < 0.01; ⁄⁄⁄p < 0.001. Mann–Whitney FPG(+) versus FPG():
cp < 0.001.
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tration tested (0.15 lM). At the same concentration, the pre-treat-
ment exhibited moderate inhibition (47.8%).3.3. Mutagenicity
Table 1 shows that CASB was not mutagenic to S. typhimurium
strains TA 98 and TA 102 with and without metabolization. That
the mutagenic index was <2 demonstrates that the compound
tested could not induce an increase in the number of revertants.3.4. Antimutagenicity
The results of the antimutagenicity assay for CASB are shown in
Table 2. The compound was used in association with MMC and AFBFig. 4. (A) Antigenotoxicity in the HepG2 cell line both pre- and post-treated with CAS
comet assay and incubated with FPG enzyme. NC = negative control (cells in cell culture
Hank’s 0, 5% in DMEM and exposed to H2O2). Kruskal–Wallis with Dunn post-test VC ver
by the antigenotoxicity treatment described in A. Negligible (20–0%), weak (40–21%), min the strain TA 98 under metabolization (+S9) and in the strain TA
102 without metabolization (S9). The combination of CASB
(0.10 mg/plate) with the mutagens AFB and MMC resulted in a via-
bility of 100% and 69%, respectively, which are acceptable to per-
form the antimutagenicity assay. Under metabolization using the
strain TA 98, CASB was a strong inhibitor (approximately 90%)
against DNA damage induced by AFB. For the strain TA 102 without
metabolization, CASB was a weak (40–21%) or moderate (41–60%)
inhibitor against the mutagenicity induced by MMC.3.5. Antioxidant assay
The results of the antioxidant assay (Fig. 5) show that CASB was
able to signiﬁcantly reduce ROS generated by H2O2 at the two high-
er concentrations tested (0.08 and 0.15 lM) compared with the
vehicle control (Fig. 5B). These results corroborate the H2O2 DNA
damage reduction shown in the post-treatment with CASB as-
sessed by the comet assay, as shown in Fig. 4A.4. Discussion
The present study assessed the mutagenic/genotoxic, antimuta-
genic/antigenotoxic and antioxidant activities of CASB in S.
typhimurium and HepG2 cell lines. Recently, natural products have
been suggested to possess DNA protective and antioxidant proper-
ties (Dellai et al., 2009; Gupta et al., 2009), which can be useful to
prevent diseases such as cancer.
The S. typhimurium strains TA 98 and TA 102 were used in the
Ames test. The TA 98 strain has a speciﬁc deletion in the plasmid
pKM 101 that makes this strain reversible in frameshift events
(Maron and Ames, 1983). S. typhimurium TA 102 is susceptible to
oxidative damage due to a mutation in the gene G428 (Levin
et al., 1982).
CASB was not mutagenic to the strains TA 98 and TA 102. As de-
scribed previously, these results indicate that the compound did
not induce signiﬁcant frameshift events or oxidative damage at
the concentrations tested.
However, CASB was genotoxic at concentrations below the IC20
to the HepG2 cells. Interestingly, when the enzyme FPG was used,
the genotoxicity increased signiﬁcantly compared to the assayB for 24 h against the damage caused by H2O2 (1 mM), which was assessed by the
medium, DMEM); VC = vehicle control (cells pre- or post-treated with DMSO 0.05%,
sus treatments: ⁄p < 0.05; ⁄⁄p < 0.01;⁄⁄⁄p < 0.001. (B) Inhibition of H2O2 DNA damage
oderate (60–41%) and strong (higher than 60%).
Table 1
Mutagenic activity of CASB in strains of S. typhimurium TA 98 and TA 102 in the presence (+S9) and absence (S9) of metabolization.
Salmonella typhimurium revertants/plate ±SD (MI)
mg/plate TA 98 TA 102
S9 +S9 S9 +S9
DMSO 71.0 ± 5.6 70.3 ± 11.2 208.0 ± 14.4 317.3 ± 20.2
0.03 78.3 ± 10.3 (1.1) 76.0 ± 16.2(1.1) 211.3 ± 54.3 (1.0) 284.3 ± 3.1 (0.9)
0.05 74.7 ± 15.1 (1.1) 94.3 ± 19.9 (1.3) 217.0 ± 23.5 (1.0) 296.0 ± 24.3 (0.9)
0.10 76.0 ± 12.1 (1.1) 79.0 ± 24.4 (1.1) 188.3 ± 34.1 (0.9) 273.7 ± 13.8 (0.9)
0.15 77.7 ± 20.5 (1.1) 94.3 ± 9.3(1.3) 179.0 ± 24.6 (0.9) 297.7 ± 35.3 (0.9)
0.21 59.3 ± 7.4 (0.8) 88.7 ± 2.1 (1.3) 193.3 ± 33.7 (0.9) 260.7 ± 41.4 (0.8)
Control + 1749.3 ± 152.5 460.0 ± 20.0 1438.3 ± 160.3 371 ± 35.7
MI = Mutagenesis index; SD = standard deviation; Control +: TA 102 (S9) MMC (0.5 lg/plate), TA 102 (+S9) 2-AF (10 lg/plate), TA 98 (S9) NPD (10 lg/plate), TA98 (+S9) 2-
AN (1.25 lg/plate). DMSO (100 lL/plate) = negative control.
Table 2
Antimutagenicity assay. S. typhimurium revertants per plate treated with CASB in association with mitomycin C (MMC) and aﬂatoxin B1 (AFB) in strain TA 98 under
metabolization (+S9) and strain TA 102 without metabolization (S9).
Salmonella typhimurium revertants/plate ±SD (I)
TA 98 (+S9) TA 102 (S9)
mg/plate mg/plate
AFB (5  107) 349.7 ± 0.6 MMC (4  107) 690.7 ± 90.9
DMSO 30.3 ± 3.1 DMSO 209.3 ± 10.1
CASB + AFB (5  107) MID50 CASB + MMC (4  107) MID50
0.02 34.3 ± 4.5 (90.2)d 0.003 0.02 650.7 ± 101.9 (5.8)a 0.04
0.03 39 ± 6 (88.8)d 0.03 364 ± 31.4 (47.3)c
0.05 33.3 ± 2.5 (90.5)d 0.05 395.7 ± 47.2 (42.7)c
0.1 35.7 ± 1.5 (89.8)d 0.1 280.7 ± 4.2 (59.4)c
I = percent inhibition; SD = standard deviation; CASB = CASB; DMSO (100 lL/plate) = negative control; I = anegligible (20–0%), bweak (40–21%), cmoderate (60–41%) and
dstrong (higher than 60%); MID50 = concentration of CASB (mgnplate) that inhibits 50% of mutagenicity.
Fig. 5. Antioxidant activity using DCFDA in the HepG2 cell line pre-treated for 24 h with CASB against ROS generated by H2O2. (A) Curve of ﬂuorescence intensity obtained in
30 min of reaction. (B) Total intensity obtained by the integral of the curves presented in A. NC = negative control (cells in cell culture medium, DMEM); VC = vehicle control
(cells pre-treated with DMSO 0.05%, Hank’s 0.5% in DMEM and exposed to H2O2). Q = quercetin control (40 lM). B 0.04 = CASB 0.04 lM. B 0.08 = CASB 0.08 lM. B 0.15 = CASB
0.15 lM. Kruskal–Wallis with Dunn post-test VC versus treatments: ⁄p < 0.05; ⁄⁄p < 0.01; ⁄⁄⁄p < 0.001.
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tive damage to DNA with a concentration–response proﬁle.
Although this mechanism has not been elucidated for CASB, de
Carvalho et al. (1998) demonstrated that two different diterpene
clerodanes extracted from C. sylvestris, known as casearins S and
T, caused acetylation of the DNA molecule when measured by
DNA damage detection in cells of Saccharomyces cerevisiae mu-
tants. Therefore, the interactions of casearins with DNA may be
associated with the genotoxic effects observed in this study.Additionally, Zeiger (2007) notes that DNA damage protection
studies have to be conducted in parallel with mutagenicity and
cytotoxicity assays to guarantee their safety and avoid overestima-
tion of the chemopreventive effects observed, respectively. Thus,
our DNA damage protection studies were performed using non-
cytotoxic and non-genotoxic/mutagenic conditions.
Compounds that protect DNA from damage can act by two dif-
ferent mechanisms. They can be considered desmutagens, which
reduce the mutagenic/genotoxic effect by directly interacting with
158 A.M. Prieto et al. / Food and Chemical Toxicology 53 (2013) 153–159the mutagens, block their effects by inhibiting their metabolic acti-
vation or enhance their detoxiﬁcation. The pre-treatment is com-
monly performed to assess the detoxiﬁcant properties of the
compounds, since detoxiﬁcant enzymes can be induced during
the pre-treatment period. Alternatively, these compounds can be
classiﬁed as bioantimutagens, which promote DNA repair after
damage, increase DNA replication, inhibit error-prone replication
or suppress the growth and replication of cells with damaged
DNA .The post-treatment is useful to assess bioantimutagenic ef-
fects, for instance DNA repair response can be activated after dam-
age, and the post-treatment can help to improve this effect (Kada
and Shimoi, 1987). The results obtained for CASB are interesting
because in the antigenotoxicity assay in the HepG2 cell line, CASB
protected the DNA against oxidative damage at lower concentra-
tions with both pre- and post-treatment (Fig. 4). Additionally, the
compound also protected the DNA against oxidative damage in
TA102 when exposed to MMC (Table 2).
Taken together, the data shown in the genotoxicity and anti-
genotoxicity assays are particularly interesting. They corroborate
previous results obtained in animal models for compounds from
C. sylvestris, where a weak genotoxic response and an antigeno-
toxic activity were observed concurrently in the comet assay at
the same concentrations (de Oliveira et al., 2009). In addition, other
studies described the same proﬁle for compounds derived from
natural products (Miyaji et al., 2004). Speciﬁcally, with regard to
derivatives of C. sylvestris, the possible acetylation of DNA that gen-
erates a genotoxic response may also be responsible for the acety-
lation of histones. It is already known that histone acetylation
results in DNA relaxation; thus, the DNA becomes accessible to
the transcriptional machinery (Sterner and Berger, 2000), thereby
enabling the correction of lesions, either by the DNA repair mech-
anism or by the transcription of detoxiﬁcant enzymes (Li et al.,
2007). Concerning the detoxiﬁcant activity, the results of post-
treatment with CASB in the comet assay (Fig. 4) can be explained
by the antioxidant DCFDA assay results, which show that CASB sig-
niﬁcantly induced antioxidant enzymes that reduce ROS generated
by H2O2 (Fig. 5). This ﬁnding explains why both a desmutagenic
and a bioantimutagenic response were observed in this work,
and why de Oliveira et al. (2009) observed protection to damage
induced by cyclophosphamide in an animal model.
Complementarily, to the comet assay the use of 24 h treatment
was performed to allow the cell to complete one entire cell cycle,
consequently, it was possible to express DNA repair machinery
(post-treatment) or induce antioxidant enzymes (pre-treatment).
Because of this, there was a difference in the percent DNA damage
in the comet tail observed in both pre- and post-treatments that
was clearly observed in the vehicle controls. The explanation for
this result is that the pre-treatment consists of treating cells with
vehicle control or compound, then inducing genotoxic damage fol-
lowed by the comet assay. Damage occurs, but the repair system of
the cell does not have enough time to repair it; therefore, higher
values of damage are observed. However, with the post-treatment,
damage is generated and then the treatments are added for 24 h,
thus allowing the time required for the cell to repair any damage
spontaneously, resulting in the vehicle control showing less dam-
age after the post-treatment compared to pre-treatment. However,
there is signiﬁcant residual damage (shown in vehicle control) that
the cell cannot repair itself, and the possible reduction of this dam-
age is evaluated with the post-treatment of cells with the
compounds.
Additionally, compared to other compounds that are antimuta-
genic and antioxidant, such as N-acetyl-L-cysteine (MID50 = 0.07 -
mg/plate; TA 100; against 4-nitroquinoline 1-oxide) or myrcetin,
a ﬂavonoid extracted from natural products (MID50 = 0.16 mg/
plate; TA 98; S9 incubation, against cigarette smoke condensate)
(Camoirano et al., 1994), CASB was most efﬁcient on protectingDNA from damage once it presented a MID50 lower than N-acet-
yl-L-cysteine or myrcetin as shown in Table 2: (MID50 = 0.04 mg/
plate; TA 102; against MMC); (MID50 = 0.003 mg/plate; TA 98; S9
incubation; against AFB).
In the Ames test, CASB strongly inhibited the effects of AFB in
the TA 98 strain under metabolization in the antimutagenesis as-
say. These results indicate that CASB interacts with AFB and may
inhibit the microsomal activation of AFB to electrophilic metabo-
lites (Ammar et al., 2008). In the TA 102 strain, a lower inhibition
of the direct agent MMCwas observed when compared to AFB. This
result demonstrates that CASB is highly efﬁcient in protecting DNA
from damage under a metabolization model.
In conclusion, CASB showed interesting chemopreventive char-
acteristics in both HepG2 cells and S. typhimurium strain by pro-
tecting DNA against different types of damage and by acting as
an antioxidant through inducing detoxiﬁcant enzymes in HepG2
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